KUPANDO is a pioneering Berlin-based biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunityto provide, not only a safe but also affordable, immunotherapy to cancer patients, and to develop immunostimulatory agents with the means to prevent infectious diseases.